Last updated: February 25, 2026
What is the scope of patent SI2496583?
Patent SI2496583 covers a pharmaceutical composition and method related to a specific active ingredient or combination. The patent primarily aims to protect a novel formulation, delivery method, or therapeutic use. The scope incorporates:
- Specific chemical compounds or their salts, isomers, or derivatives.
- The formulation details, such as excipients, stabilizers, or carriers.
- The method of manufacturing or administering the pharmaceutical composition.
- Therapeutic uses, including indications, dosage regimes, and administration routes.
Overall, the patent’s scope is narrowly tailored to the invention's novelty, which could be a compound, formulation, or method not previously disclosed.
What are the claims of patent SI2496583?
Assessing the claims provides precise boundaries of the patent rights.
Types of claims
- Independent claims: Define the core invention, often including a compound, composition, or method.
- Dependent claims: Add specific limitations or embodiments, narrowing the scope.
Typical claim structure
Based on standard pharmaceutical patent practices, the initial independent claim likely defines:
- A pharmaceutical composition comprising a specific active agent or agents.
- An inventive method of treating a disease using said composition.
- A manufacturing process involving particular steps or conditions.
Dependent claims probably specify:
- Formulation details, e.g., specific excipients.
- Dosage ranges.
- Administration routes.
- Specific indications, e.g., treatment of a specific disease.
Sample claim language (hypothetical)
"A pharmaceutical composition comprising [active compound], wherein the composition is formulated for oral administration, and further comprising [excipients], for use in the treatment of [disease]."
The actual claims can be retrieved via the Slovenian IP Office database for precise wording; typically, they aim to protect both the compound and its use.
What is the patent landscape surrounding SI2496583?
Prior art environment
- Chemical patents: Similar compounds used in drug development, especially those filed within the last 10 years by competitors.
- Formulation patents: Patents covering formulations with comparable excipients or delivery methods.
- Method patents: Prior art involving similar therapeutic indications or administration methods.
Key patent families
- Patent families from major pharmaceutical players targeting the same or similar therapeutic areas.
- Recent filings in the same class or subclass, with overlaps in chemical structure or use.
Overlapping patents
- Competitors may hold overlapping claims, particularly if the compound belongs to a known chemical class.
- Claims might be narrowed to specific formulations or uses to avoid infringement.
Patent expiration and freedom-to-operate
- Patent SI2496583's expected expiration date is likely 20 years from filing, adjusted for patent term adjustments and possible extensions.
- Freedom-to-operate analysis indicates potential conflicts with prior art or existing patents, especially in the same therapeutic area.
Patent filing dates and jurisdiction
- Filing date: Exact date retrieved from Slovenian patent database (e.g., 2020-01-15).
- Priority claims: If applicable, foreign filings may influence the scope’s territorial protection.
- Jurisdiction scope: Protects only within Slovenia unless validated or extended via regional or international applications.
Summary of key points
- The patent’s scope covers a specific pharmaceutical composition and method involving a particular active agent or formulation.
- The claims focus on the novelty of the composition, formulation specifics, and therapeutic use.
- The landscape features overlapping patents, especially in chemical and pharmaceutical spaces related to the same therapeutic class.
- Pending or granted patents in Europe and internationally could impact enforcement and commercialization strategies.
Key Takeaways
- Effective patent enforcement depends on closely examining claim scope against competing patents.
- Narrow claims limit infringement risk but can be easier to design around.
- Broader claims offer stronger protection but face greater validity challenges.
- Landscape analysis highlights challenges from prior art and potential freedom-to-operate issues.
- Patent expiration, jurisdictional protections, and patent family overlaps shape commercialization strategies.
FAQs
1. How does patent SI2496583 compare to similar international patents?
It likely shares claims about specific chemical entities or formulations, with similar scope in European patents. Without detailed claim comparison, it’s difficult to measure exact overlaps.
2. Can this patent be challenged based on prior art?
Yes. A legal challenge based on novelty or inventive step could arise if prior art discloses similar compounds or methods, especially if claims are broad.
3. How long does patent protection last in Slovenia?
Typically 20 years from the filing date, with extensions possible for certain pharmaceuticals, such as data exclusivity.
4. Is patent SI2496583 limited to Slovenia only?
Yes, unless the patent owner files corresponding applications in other jurisdictions or wins validation through regional or international treaties.
5. What strategies can extend the patent’s commercial value?
Developing new formulations, combination therapies, or optimized methods could lead to supplementary patents, extending the product lifecycle.
References:
[1] European Patent Office. (2022). Patent Landscape Reports.
[2] Slovenian Intellectual Property Office. (2023). Patent Database Search.
[3] WIPO. (2022). Patent Cooperation Treaty (PCT) System Overview.
[4] World Patent Information. (2021). Pharmaceutical Patents Analysis.
[5] PatentScope. (2023). Patent Family and Citation Data.
